• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Editorial Staff
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Zagazig University Medical Journal
Articles in Press
Current Issue
Journal Archive
Volume Volume 25 (2019)
Issue Issue 1
Volume Volume 24 (2018)
Volume Volume 23 (2017)
Volume Volume 22 (2016)
Volume Volume 21 (2015)
Volume Volume 20 (2014)
Volume Volume 19 (2013)
soliman, A., El Ebeary, M., Gouda, T., Ebied, A. (2019). SERUM MATRIX METALLOPROTEINASE-2 AS A BIOMARKER FOR DIAGNOSIS OF IDIOPATHIC EPILEPSY. Zagazig University Medical Journal, 25(1), 155-163. doi: 10.21608/zumj.2019.24912
Ali Mohamed soliman; Mahmoud El Sayed El Ebeary; Tarek Abdel Rahman Gouda; Ahmed Ahmed Ebied. "SERUM MATRIX METALLOPROTEINASE-2 AS A BIOMARKER FOR DIAGNOSIS OF IDIOPATHIC EPILEPSY". Zagazig University Medical Journal, 25, 1, 2019, 155-163. doi: 10.21608/zumj.2019.24912
soliman, A., El Ebeary, M., Gouda, T., Ebied, A. (2019). 'SERUM MATRIX METALLOPROTEINASE-2 AS A BIOMARKER FOR DIAGNOSIS OF IDIOPATHIC EPILEPSY', Zagazig University Medical Journal, 25(1), pp. 155-163. doi: 10.21608/zumj.2019.24912
soliman, A., El Ebeary, M., Gouda, T., Ebied, A. SERUM MATRIX METALLOPROTEINASE-2 AS A BIOMARKER FOR DIAGNOSIS OF IDIOPATHIC EPILEPSY. Zagazig University Medical Journal, 2019; 25(1): 155-163. doi: 10.21608/zumj.2019.24912

SERUM MATRIX METALLOPROTEINASE-2 AS A BIOMARKER FOR DIAGNOSIS OF IDIOPATHIC EPILEPSY

Article 20, Volume 25, Issue 1, January 2019, Page 155-163  XML PDF (1.22 MB)
Document Type: Original Article
DOI: 10.21608/zumj.2019.24912
Authors
Ali Mohamed soliman; Mahmoud El Sayed El Ebeary; Tarek Abdel Rahman Gouda; Ahmed Ahmed Ebied
Abstract
Background: Epilepsy is a common serious neurological disorder. Medical histories and electroencephalogram (EEG) are not always sufficient for epilepsy diagnosis; therefore, exploring novel methods for the accurate diagnosis of epilepsy is of great importance. Recent studies indicate that Matrix metalloproteinases (MMPs) especially MMP-2 is sensitive to seizures thus; MMP-2 may be a potential biomarker for epilepsy diagnosis. Subject and method: Thirty four epileptic patients older than 2 years subjected to: Detailed medical history, general and neurological examination, routine laboratory studies, EEG , Brain magnetic resonance imaging (MRI), and serum MMP-2 level measurement . Thirty four age and sex matched healthy controls were selected and their serum MMP-2 were obtained. Results: serum MMP-2 levels were statistically significantly low in patient with idiopathic epilepsy compared to control group .Levels were less in patient with focal epilepsy than those with generalized epilepsy.Serum MMP-2 was lower in drug resistant epileptic patients and highest in newly diagnosed patients with negative correlation observed between duration of epilepsy and MMP-2 levels. Sensitivity of MMP-2 as biomarker was 85.29% with 97.06 % specificity. Conclusion: MMP-2 levels decreased in patients with epilepsy especially those with focal seizures. This tool may be a helpful diagnostic biomarker for epilepsy with a good sensitivity and specificity.
Keywords
Epilepsy biomarker; MMP-2. Matrix metalloproteinases
Statistics
Article View: 23
PDF Download: 23
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.